Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 17, 2026
Cancer-induced neuronal injury as a driver of immunotherapy resistance.
Journal: Immunotherapy
Published: May 19, 2026
β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 04, 2025
Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 11, 2025
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma.
Journal: Nature communications
Published: March 18, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target.
Journal: Nature communications
Published: December 07, 2024
CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated head and neck squamous cell carcinoma.
Journal: Frontiers in immunology
Published: November 15, 2024
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy.
Journal: Nature communications
Published: October 28, 2024
Spatial biology reveals altered macrophage states in immunosuppressed non-melanoma skin cancer.
Journal: Cell
Published: August 18, 2024
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.
Journal: The Journal of experimental medicine
Published: May 03, 2024
Last Updated: 09/26/2026